Journal article · 2026

Tolerogenic Nanovaccine Synergizing Citrullinated Peptide and TSP‐1 Plasmid for Antigen‐Specific Immunotherapy of Rheumatoid Arthritis

Mo Chen, Die Jia, Yinlong Wu, Ke Wang, Xing Zhao, Xing Guo, Shaobing Zhou

Small, 22(37), e73817 · Published 17 May 2026 · DOI 10.1002/smll.73817

View at the publisherCite this paper

In brief

“Tolerogenic Nanovaccine Synergizing Citrullinated Peptide and TSP‐1 Plasmid for Antigen‐Specific Immunotherapy of Rheumatoid Arthritis” is a 2026 journal article by Mo Chen and 6 co-authors, published in Small. OpenAlex counts 1 citations as of 18 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
3.06
References
43
Authors
7

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disorder driven by systemic inflammation and progressive joint damage. While antigen-specific immune tolerance holds promise as a therapeutic strategy, its clinical translation is hampered by the rapid clearance and unintended immunogenicity associated with conventional antigen delivery. To address these limitations, we developed a tolerogenic nanovaccine (CMLT) that co… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Chen, M., Jia, D., Wu, Y., Wang, K., Zhao, X., Guo, X., & Zhou, S. (2026). Tolerogenic Nanovaccine Synergizing Citrullinated Peptide and TSP‐1 Plasmid for Antigen‐Specific Immunotherapy of Rheumatoid Arthritis. Small, 22(37), e73817. https://doi.org/10.1002/smll.73817

MLA 9

Chen, Mo, et al. “Tolerogenic Nanovaccine Synergizing Citrullinated Peptide and TSP‐1 Plasmid for Antigen‐Specific Immunotherapy of Rheumatoid Arthritis.” Small, vol. 22, no. 37, 2026, p. e73817. https://doi.org/10.1002/smll.73817.

Chicago

Chen, Mo, Die Jia, Yinlong Wu, Ke Wang, Xing Zhao, Xing Guo, and Shaobing Zhou. 2026. “Tolerogenic Nanovaccine Synergizing Citrullinated Peptide and TSP‐1 Plasmid for Antigen‐Specific Immunotherapy of Rheumatoid Arthritis.” Small 22 (37): e73817. https://doi.org/10.1002/smll.73817.

Harvard

Chen, M. et al. (2026) ‘Tolerogenic Nanovaccine Synergizing Citrullinated Peptide and TSP‐1 Plasmid for Antigen‐Specific Immunotherapy of Rheumatoid Arthritis’, Small, 22(37), p. e73817. doi:10.1002/smll.73817.

IEEE

M. Chen et al., “Tolerogenic Nanovaccine Synergizing Citrullinated Peptide and TSP‐1 Plasmid for Antigen‐Specific Immunotherapy of Rheumatoid Arthritis,” Small, vol. 22, no. 37, p. e73817, 2026, doi: 10.1002/smll.73817.

BibTeX

@article{chen2026tolerogenic,
  title     = {{Tolerogenic Nanovaccine Synergizing Citrullinated Peptide and TSP‐1 Plasmid for Antigen‐Specific Immunotherapy of Rheumatoid Arthritis}},
  author    = {Chen, Mo and Jia, Die and Wu, Yinlong and Wang, Ke and Zhao, Xing and Guo, Xing and Zhou, Shaobing},
  journal   = {Small},
  year      = {2026},
  volume    = {22},
  number    = {37},
  pages     = {e73817},
  doi       = {10.1002/smll.73817},
  url       = {https://doi.org/10.1002/smll.73817}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies

  • rheumatoid arthritis
  • citrullinated peptides
  • thrombospondin-1
  • lipid nanoparticles
  • antigen-specific immunotherapy
  • collagen-induced arthritis
  • regulatory T cells
  • TGF-β1

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Chen, M., Jia, D., Wu, Y., Wang, K., Zhao, X., Guo, X., & Zhou, S. (2026). Tolerogenic Nanovaccine Synergizing Citrullinated Peptide and TSP‐1 Plasmid for Antigen‐Specific Immunotherapy of Rheumatoid Arthritis. Small, 22(37), e73817. https://doi.org/10.1002/smll.73817

How many times has this paper been cited?

1 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Mo Chen, Die Jia, Yinlong Wu, Ke Wang, Xing Zhao, Xing Guo, Shaobing Zhou.

What is the DOI of this paper?

10.1002/smll.73817, permanently at https://doi.org/10.1002/smll.73817. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.